Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ayursulin
- Development stage
- Unknown
- Lead developer
- Bal Pharma
- Administration
- Oral
01
Overview
Ayursulin is a polyherbal Ayurvedic formulation developed and marketed by Bal Pharma Limited under its Bal Vedics division. It is primarily indicated for the management of blood sugar levels and Polycystic Ovary Syndrome (PCOS). The formulation is composed of several traditional medicinal herbs, including Amalaki (*Emblica officinalis*), Haridra (*Curcuma longa*), Guduchi (*Tinospora cordifolia*), Bilva (*Aegle marmelos*), and Kalamegha (*Andrographis paniculata*). Ayursulin is designed to support glucose metabolism, provide antioxidant protection to the pancreas, and exert antihyperlipidaemic effects. It is available in capsule form for oral administration and is currently approved and marketed in India.
- Brand names
- Ayursulin
Beyond the preview
Go deeper on Ayursulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ayursulin.